Integrins as Therapeutic Targets for SARS-CoV-2.
Gressett TE, Nader D, Robles JP, Buranda T, Kerrigan SW, Bix G.
Gressett TE, et al. Among authors: buranda t.
Front Cell Infect Microbiol. 2022 Apr 29;12:892323. doi: 10.3389/fcimb.2022.892323. eCollection 2022.
Front Cell Infect Microbiol. 2022.
PMID: 35619646
Free PMC article.
No abstract available.